{
  "meta": {
    "title": "101_Community_Medicine_Neet_2022",
    "url": "https://brainandscalpel.vercel.app/101-community-medicine-neet-2022-15a70847.html",
    "scrapedAt": "2025-11-30T12:55:42.254Z"
  },
  "questions": [
    {
      "text": "The average life expectancy for a woman in Japan is 87 years. Due to recent advances in testing for cervical cancer, there is an increase in life expectancy by 15 years. The healthcare utility value is 0.8. Which of the following can be calculated from the parameters given?",
      "choices": [
        {
          "id": 1,
          "text": "HALE"
        },
        {
          "id": 2,
          "text": "DALY"
        },
        {
          "id": 3,
          "text": "DFLE"
        },
        {
          "id": 4,
          "text": "QALY"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>QALY&nbsp;</strong>(quality-<span tabindex=\"0\" role=\"tooltip\"><span class=\"povykd\" tabindex=\"0\" role=\"button\" data-enable-toggle-animation=\"true\" data-extra-container-classes=\"ZLo7Eb\" data-hover-hide-delay=\"1000\" data-hover-open-delay=\"500\" data-send-open-event=\"true\" data-theme=\"0\" data-width=\"250\" data-ved=\"2ahUKEwiEy-CYpoL5AhWqUGwGHUOYBkkQmpgGegQIBhAD\"><span class=\"JPfdse\" data-bubble-link=\"\" data-segment-text=\"adjusted life-year\">adjusted life year</span></span></span><span tabindex=\"0\" role=\"tooltip\"><span class=\"povykd\" tabindex=\"0\" role=\"button\" data-enable-toggle-animation=\"true\" data-extra-container-classes=\"ZLo7Eb\" data-hover-hide-delay=\"1000\" data-hover-open-delay=\"500\" data-send-open-event=\"true\" data-theme=\"0\" data-width=\"250\" data-ved=\"2ahUKEwiEy-CYpoL5AhWqUGwGHUOYBkkQmpgGegQIBhAD\"><span class=\"JPfdse\" data-bubble-link=\"\" data-segment-text=\"adjusted life-year\">)&nbsp;</span></span></span>can be calculated by the <strong>utility value</strong>.&nbsp;</p>\n<p>QALY is a <strong>disability rate</strong> indicator. It is based on the <strong>number of years</strong> that would be <strong>added to life</strong> due to <strong>medical intervention.</strong> A utility value of&nbsp;<strong>1.0</strong> is given for each year of&nbsp;<strong>perfect health </strong>and <strong>0</strong> for <strong>death</strong>.&nbsp;It is the measure of the disease burden which includes both quality and quantity of life.</p>\n<p><strong>Disability rates</strong> that are related to illness and injury are used as supplementation to mortality and morbidity indicators. It is based on the concept that a <strong>full range </strong>of <strong>daily activities</strong> implies good health. It is divided into:</p>\n<ul>\n<li><strong>Event-type indicators</strong>: It counts the number of days of restricted activity, bed disability days, and work loss days.</li>\n<li><strong>Person-type indicators</strong>: It counts limitation of mobility and limitation of activity.&nbsp;</li>\n</ul>\n<p>Other options:</p>\n<p>Option A: <strong>HALE</strong>&nbsp;(health adjusted life expectancy) is an&nbsp;indicator that estimates the number of&nbsp;<strong>years</strong>&nbsp;a <strong>newborn</strong> is <strong>expected</strong> to <strong>live</strong>&nbsp;in<strong> full health</strong>&nbsp;based on the&nbsp;<strong>current rates</strong>&nbsp;of<strong>&nbsp;ill health</strong>&nbsp;and&nbsp;<strong>mortality</strong>. HALE&nbsp;is calculated using the&nbsp;<strong>life expectancy&nbsp;</strong>at<strong>&nbsp;birth</strong>&nbsp;with an&nbsp;<strong>adjustment&nbsp;</strong>for time spent in<strong>&nbsp;poor health</strong>. It was known as&nbsp;<strong>DALE&nbsp;</strong>(disability-adjusted life expectancy) previously.&nbsp;</p>\n<p>Option B: <strong>DALY </strong>(disability adjusted life years) is an indicator that estimates&nbsp;the <strong>number </strong>of <strong>years lost</strong> due to ill-health, disability, or early death. It is calculated by:</p>\n<p>DALY=<strong> Years of life lost </strong>(YLL) +<strong> Years lived with disability </strong>(YLD)</p>\n<p>Option C: <strong>DFLE </strong>(disability-free life expectancy) is an indicator that estimates the average number of years an <strong>individual</strong> is<strong> expected </strong>to<strong> live free </strong>of <strong>disability</strong> if the current pattern of mortality and disability continues to apply. It is also known as <strong>active life expectancy&nbsp;</strong>and is calculated by:</p>\n<p>DFLE =&nbsp;<strong>Life expectancy&nbsp;</strong>-<strong> Duration of disability</strong></p><hr><h3>Related Pearl: QALY vs. DALY</h3><p>QALY and DALY are disability indicators used as measures of health in a population.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>QALY </strong>(Quality Adjusted Life Years)</p>\n</td>\n<td>\n<p><strong>DALY&nbsp;</strong>(Disability Adjusted Life Years)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>Measures <strong>quality of life</strong> in health gain</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>Measures <strong>health loss</strong> in quality of life</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>Indicator of <strong>cost-effectiveness</strong> of intervention</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>Indicator of overall <strong>burden of disease</strong> in a population</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>Expressed as 1 or 0 where,</p>\n<p>1 = Perfect health</p>\n<p>0 = Death</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>Expressed as 0 or 1 where,</p>\n<p>0 = Perfect health</p>\n<p>1 = Death</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: HDI vs. PQLI</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Human Development Index&nbsp;</strong><strong>(HDI)</strong></p>\n</td>\n<td><strong>Physical Quality of Life Index (PQLI)</strong></td>\n</tr>\n<tr>\n<td><strong>Components</strong></td>\n<td>\n<p>Longevity (Life expectancy at birth)</p>\n<p>A decent standard of living (Real GNI per capita in PPP US$)</p>\n<p>Knowledge (mean years of schooling and expected years of schooling)</p>\n</td>\n<td>\n<p>Life expectancy at 1 year of age&nbsp;</p>\n<p>Infant Mortality rate</p>\n<p>Literacy rate</p>\n</td>\n</tr>\n<tr>\n<td><strong>Range</strong></td>\n<td>0 to +1</td>\n<td>0 to 100</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5455",
      "difficulty": "medium"
    },
    {
      "text": "You are working in a primary health center (PHC) situated in a high seismic zone. Which of the following will you do as part of preparedness for an emergency?<div class='question-desc-html'><p>1. Disaster preparedness by making sure all financial and other resources are available <br />2. Increase public awareness through campaigns and loudspeakers<br />3. Conduct a simulation for the disaster and assess the response<br />4. Follow instructions given over the phone or radio by higher officials</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 3, 4"
        },
        {
          "id": 2,
          "text": "2, 3, 4"
        },
        {
          "id": 3,
          "text": "1, 2, 3"
        },
        {
          "id": 4,
          "text": "1, 2, 4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Steps</strong> <strong>1, 2, </strong>and<strong> 3</strong> are done as part of <strong>preparedness</strong> for an emergency by someone working in a PHC situated in a high seismic zone.</p>\n<p><strong>Emergency preparedness</strong> refers to <strong>long-term development activities</strong> that strengthen the capacity of a country to effectively <strong>manage</strong> all kinds of <strong>emergencies</strong>. It involves the following steps:</p>\n<ol>\n<li>Disaster preparedness by making sure all <strong>financial </strong>and other resources are <strong>available</strong></li>\n<li><strong>Increase public awareness</strong> through campaigns and loudspeakers</li>\n<li>Conduct a <strong>simulation</strong> for the disaster and assess the response</li>\n<li>Evaluate the risk of disaster</li>\n<li>Information sessions coordination with news media</li>\n<li>Adopt standards and regulations</li>\n</ol>\n<div class=\"page\" title=\"Page 867\"><strong>Disaster risk management</strong> is a systematic process using administrative decisions, policies, and strategies to lessen the impacts of natural hazards and disasters. The steps are:</div>\n<ul>\n<li><strong>Response</strong> - This includes activities such as:<br />\n<ul>\n<li>Search, rescue, and first aid: This step is important since the organized relief services will be able to address only a small fraction of demand after a major disaster.</li>\n<li>Field care: This includes making health care available regardless of facilities and operating status. </li>\n<li>Triage: <strong>Classifying</strong> the <strong>injured</strong> based on the <strong>severity</strong> of the <strong>injuries</strong> and chances of survival with medical intervention. </li>\n<li>Tagging: Tags with name, age, triage category, diagnosis and treatment are put for identification purposes. </li>\n<li>Identification of the dead: The dead bodies should be shifted from the disaster site to the mortuary.</li>\n</ul>\n</li>\n<li><strong>Rehabilitation</strong> - This includes <strong>measures</strong> that lead to the <strong>restoration </strong>of <strong>pre-disaster conditions. </strong>These measures include water supply restoration, food safety, basic sanitation, personal hygiene, and vector control.</li>\n<li><strong>Mitigation </strong>- This includes <strong>measures</strong> to<strong> prevent disasters</strong> from <strong>causing emergencies</strong> or to lessen the likely effects of emergencies<strong>. </strong>Some of them are flood mitigation, land use planning, improved building codes, and the reduction and protection of vulnerable populations or structures. </li>\n<li><strong>Preparedness</strong> - This is a program that aims at <strong>strengthening</strong> the <strong>capacity</strong> of a <strong>country</strong> to manage all types of emergencies efficiently. Its <strong>objective</strong> is to ensure that appropriate measurements are taken for the <strong>relief</strong> and <strong>rehabilitation</strong> of disaster victims.</li>\n</ul>\n<div class=\"page\" title=\"Page 868\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Some measures that should be followed by all <strong>in case of an emergency</strong> include:</p>\n<ul>\n<li><strong>Avoiding</strong> telephone use, unless it is to call for help</li>\n<li>Listen to and carry out the radio or loudspeaker broadcast messages</li>\n<li>Carry out the official instructions given over the radio or by loudspeaker</li>\n<li>Keep a family emergency kit ready</li>\n</ul>\n</div>\n</div>\n</div>\n<p>Note: Vaccination of the general population post-disaster against typhoid, cholera, and tetanus is<strong> not recommended. </strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/809cbb270756434d8959a436b1beab42x1280x1665.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Triage Colour Coding</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/515d17fd0b684f8b9cd1fd57ef97b7e6x454x304.PNG\" alt=\"Pearl Image\"><p>&nbsp;<strong>Triage system </strong>consists of <strong>four colour codes:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Color code</strong></td>\n<td><strong>Type of patients</strong></td>\n<td><strong>Examples</strong></td>\n</tr>\n<tr>\n<td><span>Red (High priority)<br /></span></td>\n<td>\n<p>Need for<strong> immediate resuscitation or surgery</strong> in the next<strong> 6 hours</strong> or transfer.</p>\n<p>May survive if timely medical intervention can be given</p>\n</td>\n<td>\n<ul>\n<li>Tension pneumothorax</li>\n<li>Airway obstruction</li>\n<li>Hemothorax</li>\n<li>Cardiac tamponade</li>\n<li>Acute circulatory arrest</li>\n<li>Major intra-abdominal bleed etc.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Yellow (Medium priority)<br /></span></td>\n<td>\n<p>Possible <strong>resuscitation or surgery</strong> in the <strong>next 24 hours</strong>.</p>\n<p>Likely to survive if prompt treatment is given.</p>\n</td>\n<td>\n<ul>\n<li>Compound fractures</li>\n<li>Degloving injuries</li>\n<li>Pelvic fracture</li>\n<li>Spinal injuries</li>\n<li>Moderate head injury</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Green (Low priority)<br /></span></td>\n<td>\n<p><strong>Ambulatory patients</strong> or minor illnesses.</p>\n<p>Likely to survive if treatment is slightly delayed.</p>\n</td>\n<td>\n<ul>\n<li>Simple fractures</li>\n<li>Minor lacerations etc.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Black (Least priority)</td>\n<td>\n<p><strong>Dead or moribund</strong> patients.</p>\n</td>\n<td>\n<ul>\n<li>Severe brain injury</li>\n<li>Major damage / disruption to chest wall and abdominal structures</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5453",
      "difficulty": "medium"
    },
    {
      "text": "Although many animals are implicated in the spread of rabies, dogs are the most common ones. Also, it usually affects children in developing countries. Knowing this, what is the most cost-effective and logical way to reduce the incidence of rabies?",
      "choices": [
        {
          "id": 1,
          "text": "Testing all the dogs for rabies"
        },
        {
          "id": 2,
          "text": "Reduce stray dog population and vaccinate all dogs"
        },
        {
          "id": 3,
          "text": "Increase the laboratory facilities"
        },
        {
          "id": 4,
          "text": "Increase capacity of healthcare workers for surveillance"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Reducing the stray dog population</strong>&nbsp;and <strong>vaccinating all dogs</strong>&nbsp;is the most cost-effective and logical way to reduce the incidence of rabies. The Animal Birth Control initiative from the Government of India is directed towards this goal.&nbsp;</p>\n<p><strong>Rabies </strong>is a highly fatal viral disease caused by<strong><em>&nbsp;</em>Lyssavirus type 1,<em>&nbsp;</em></strong>affecting the<strong> central nervous system. Dogs</strong> are considered the major <strong>source</strong> of rabies infection. Thus immunization of dogs at the age of<strong> 3-4 months</strong> and booster doses at regular intervals is recommended to control rabies. The type of vaccines used are:</p>\n<ul>\n<li><strong>BPL inactivated nervous tissue vaccine&nbsp;</strong>- it is a <strong>single-dose</strong> vaccine. Booster is advised after <strong>6 months</strong> and subsequently&nbsp;<strong>every year</strong>.&nbsp;</li>\n<li><strong>Modified live virus vaccine&nbsp;</strong>- it is also a single-dose vaccine and a booster is given <strong>every 3 years</strong>.&nbsp;</li>\n</ul>\n<p>Other methods to <strong>control rabies</strong> include:</p>\n<ul>\n<li>Registration and licensing of all domestic dogs</li>\n<li>The immediate killing of dogs and cats bitten by rabid animals</li>\n<li>6 months quarantine for imported dogs</li>\n<li>Educating people regarding dog care and prevention of rabies.&nbsp;</li>\n</ul>\n<p>Note: <strong>Strengthening laboratory facilities</strong> and&nbsp;<strong>surveillance</strong> are also the methods used to reduce the incidence according to the <strong>National Rabies Control Program (NRCP)</strong></p>\n<p>Humans get infected after a <strong>deep bite</strong> or <strong>scratch</strong> by an infected animal. The transmission also occurs when the <strong>saliva</strong> of the infected dog comes into direct contact with human mucosa or fresh skin wounds.&nbsp;</p>\n<p>Rabies in man is also known as&nbsp;<strong>hydrophobia</strong>. The clinical features usually begin as prodromal symptoms like headache, and fever followed by<strong> neurological</strong> <strong>symptoms</strong>. The patients usually present with confusion, hallucination, irritability, hydrophobia, <strong>aerophobia</strong>, and muscle spasms. They also present with symptoms of <strong>autonomic dysfunction</strong> such as <strong>hypersalivation</strong>, lacrimation, cardiac arrhythmias, etc.&nbsp;</p>\n<p>Laboratory tests for rabies include:&nbsp;</p>\n<ul>\n<li><strong>Fluorescent antibody test</strong> is a highly reliable and best test for rapid detection of rabies antigen in the infected specimens</li>\n<li>Microscopic examination of the brain tissue to demonstrate <strong>Negri bodies</strong>.</li>\n</ul><hr><h3>Related Pearl: Rabies vaccines and immunoglobulins schedules</h3><p>According to the Ministry of Health and Family Welfare, Government of India:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f49dfa01d9bd424db725e4ebf600cb98x1280x3397.JPEG\" alt=\"Pearl Image\"><p>WHO category <strong>II</strong> or <strong>III</strong> exposures should receive&nbsp;<strong>post-exposure prophylaxis&nbsp;</strong>(PEP)<strong>&nbsp;immediately.</strong></p>\n<p>One <strong>intradermal&nbsp;</strong>(ID)&nbsp;dose is <strong>0.1 mL</strong> of vaccine and one <strong>intramuscular</strong> (IM) dose is an <strong>entire vial</strong> of vaccine, irrespective of the vial size.</p>\n<p>Should a vaccine dose be delayed for any reason, the PEP schedule should be resumed (not restarted).</p>\n<p><strong>Rabies Immunoglobulin(RIG):&nbsp;</strong></p>\n<ul>\n<li>Passive immunization</li>\n<li><strong>Single-dose</strong>; after initiation of PEP and not beyond 7 days after the first dose of vaccine</li>\n<li>Max dose: <strong>hRIG - 20IU/kg ,&nbsp;</strong><strong>eRIG</strong><strong>&nbsp;- 40IU/kg </strong>body weight</li>\n<li>Vaccines should never be withheld regardless of the availability of RIG.</li>\n<li><strong>Alternatives</strong> for RIG- WHO recommends&nbsp;<strong>m</strong><strong>onoclonal antibodies&nbsp;</strong>(mAb)&nbsp;as a 'cocktail' containing at least <strong>two antibodies</strong> against the rabies virus.</li>\n</ul>\n<p>Administration of RIG:</p>\n<ul>\n<li>RIG should be administered&nbsp;<strong>into</strong> or <strong>around</strong> the <strong>wound site</strong> or sites.</li>\n<li>The&nbsp;<strong>remaining</strong> RIG, if any, should be injected <strong>IM</strong> at a site <strong>distant</strong> from the <strong>site</strong> of vaccine administration.</li>\n<li>RIG may be diluted to a volume sufficient for all wounds to be effectively and safely infiltrated.</li>\n</ul>\n<p>Prioritization&nbsp;of RIG allocation (numbered according to priority order):</p>\n<ol>\n<li>Multiple bites</li>\n<li>Deep wounds</li>\n<li>Bites to head, neck, and hands</li>\n<li>Patients with severe immunodeficiency</li>\n<li>Confirmed/probable rabies in biting animal</li>\n<li>Bites, scratches, and exposure of mucous membranes caused by a bat</li>\n</ol>\n<p><strong>Pre-exposure prophylaxis&nbsp;(PrEP)</strong></p>\n<p>PrEP is considered in the following conditions:</p>\n<ul>\n<li>High-risk groups- laboratory staff, wildlife wardens, veterinarians, animal handlers, and travelers to endemic regions.</li>\n<li>Remote, rabies-endemic areas where access to PEP is difficult</li>\n<li>Areas where&nbsp;dog bite incidence is &gt;5% per year</li>\n<li>Areas where vampire bat rabies is known to be present.</li>\n</ul>\n<p>Pre-exposure rabies vaccination consists of <strong>3&nbsp;intramuscular (IM) or 3 intradermal (ID)</strong>&nbsp;doses. These are given on <strong>days 0, 7 and 21 or 28.</strong></p>\n<ul>\n<li>Adults - the vaccine should always be administered in the deltoid area of the arm</li>\n<li>Young children (under 1 year of age)- Administration into the anterolateral area of the thigh is recommended.</li>\n<li><strong>Rabies vaccine </strong>should<strong> never</strong> be administered in the<strong> gluteal area.</strong>&nbsp;Administration in this manner will result in <strong>lower neutralizing antibody titers.</strong></li>\n</ul>\n<p>For exposed or re-exposed patients who can document previous completion of PEP or PrEP the following guidelines would be applicable:</p>\n<ul>\n<li>Proper wound management should be done.</li>\n<li>There is no need for the administration of RIG.</li>\n<li>One site ID or IM vaccine administration on days 0 and 3.</li>\n</ul>\n<p>Only adequate wound washing would be required in case of re-exposure where the animal bite victim has documented proof of complete PEP&nbsp;<strong>within the last three months.</strong></p>\n<p>The following cases are treated as fresh cases and given full PEP:</p>\n<ul>\n<li>Those who have previously received full post-exposure treatment with neural tissue vaccines (NTV) or vaccines of unproven potency</li>\n<li>Those who cannot document complete PEP or PrEP treatment&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5450",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following steps is not included in STEP approach of WHO?",
      "choices": [
        {
          "id": 1,
          "text": "Therapeutic assessment"
        },
        {
          "id": 2,
          "text": "Physical assessment"
        },
        {
          "id": 3,
          "text": "Psychological assessment"
        },
        {
          "id": 4,
          "text": "Behavioral assessment"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Therapeutic assessment</strong> is not included in the <strong>STEP approach</strong> of WHO. </p>\n<p>STEP approach of WHO is a survey methodology developed to assess risk factors of non-communicable diseases(NCD). It helps the countries to establish an <strong>NCD surveillance system. </strong>The steps include the following:</p>\n<ul>\n<li>Questionnaires contain questions about <strong>behavioral</strong> risk factors like tobacco use, alcohol use, diet, and physical activity. </li>\n<li><strong>Physical measurements</strong> contain blood pressure, height, weight, and waist size</li>\n<li>Biochemical measurements contain blood glucose, blood lipids, urinary sodium, and creatinine.  </li>\n</ul>\n<p>Note: Mental health and suicide are included in optional behavioral risk factors (step 1). Hence, <strong>psychological assessment</strong> is also included in the STEP approach. </p>\n<p><strong>Surveillance</strong> is defined as systematic and continuous data analysis and taking appropriate preventive actions according to the results obtained. Identification of cases that are missed and not notified is known as <strong>sentinel surveillance</strong>. It is used in communicable diseases such as HIV, malaria, etc. The<strong> study population</strong> for <strong>HIV sentinel surveillance</strong> are sex workers, IV drug abusers, transgender people, migrant workers, truck drivers, etc. </p>\n<p> </p><p>The <strong>transmission assessment survey</strong> (TAS) is used to <strong>determine </strong>whether infections have been reduced below target thresholds and can the mass drug administration (MDA) be stopped. Once MDA has stopped, <strong>TAS </strong>is used as a<strong> surveillance tool</strong> to determine that infection levels are sustained below target thresholds. It is used in<strong> lymphatic filariasis. </strong></p><hr><h3>Related Pearl: Sentinel  Surveillance</h3><ul>\n<li><strong>Sentinel surveillance</strong> is used to augment the notification systems used in surveillance of diseases.</li>\n<li>It detects the total case load and is used to identify the missing cases that are not notified among the old and new cases.</li>\n<li><strong>Sentinel data</strong> from the same is extrapolated to the entire population and the prevalence can be commented on.</li>\n<li>Advantages: <strong>Bias </strong>in reporting is <strong>minimized</strong> and the <strong>feedback</strong> is simplified.</li>\n</ul><hr><h3>Related Pearl: Monitoring vs. Surveillance in Disease Control</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Monitoring</strong></p>\n</td>\n<td>\n<p><strong>Surveillance</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Performance and analysis of routine measurements aimed at detecting changes in environment or health status of a population.</p>\n</td>\n<td>\n<p>Continuous scrutiny of the factors that determine the occurrence and distribution of disease and other conditions of ill-health.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>One-time <strong>linear activity</strong></p>\n</td>\n<td>\n<p><strong>Continuous cycle</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>No feedback</strong> present</p>\n</td>\n<td>\n<p>Feedback present</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>No inbuilt action component present</p>\n</td>\n<td>\n<p><strong>Inbuilt action</strong> component present</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stops once disease is eliminated or eradicated</p>\n</td>\n<td>\n<p><strong>Continuous</strong> even after disease is eliminated or eradicated</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Smaller concept</p>\n</td>\n<td>\n<p>Broader concept</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>It is a&nbsp;<strong>part of surveillance</strong>.</p>\n</td>\n<td>\n<p>It is not a part of monitoring.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Malarial parameters</h3><p>Malarial parameters:</p>\n<table>\n<tbody>\n<tr>\n<td>Parameter</td>\n<td>Formula</td>\n</tr>\n<tr>\n<td>Annual Parasite Incidence</td>\n<td>\n<p>Confirmed cases in one year</p>\n<p>-----------------------------------&times;1000<br />Population under surveillance</p>\n</td>\n</tr>\n<tr>\n<td>Annual Blood Examination Rate</td>\n<td>\n<p>Number of slides examined</p>\n<p>-----------------------------------&times;100 <br />&nbsp; &nbsp; &nbsp; Population</p>\n</td>\n</tr>\n<tr>\n<td>Slide positivity Rate</td>\n<td>Percentage of slides found positive irrespective of species</td>\n</tr>\n<tr>\n<td>Slide Falciparum Rate</td>\n<td>Percentage of slides positive for <em>P. falciparum</em></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5446",
      "difficulty": "hard"
    },
    {
      "text": "A male patient diagnosed with tuberculosis took complete treatment. Sputum examination was done after the completion of the intensive and the continuation phases. It was found to be negative. What is the status of the patient?",
      "choices": [
        {
          "id": 1,
          "text": "Cured"
        },
        {
          "id": 2,
          "text": "Treatment completed"
        },
        {
          "id": 3,
          "text": "Lost to follow up"
        },
        {
          "id": 4,
          "text": "Treatment failed"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The negative sputum examination at the end of the treatment implies the status of the patient is <strong>cured.&nbsp;</strong></p>\n<p>Tuberculosis (TB) is a communicable disease caused by <em><strong>M</strong><strong>ycobacterium tuberculosis</strong>.</em> The disease mainly affects the lungs and causes pulmonary tuberculosis.&nbsp;</p>\n<p>A <strong>bacteriologically confirmed TB</strong> case is one in which the biological specimen tests positive on smear microscopy and culture. A clinically diagnosed TB case is one that is diagnosed as an active TB case by a clinician, who has decided to give the patient a full course of TB treatment.&nbsp;</p>\n<p>There are two phases in the treatment of TB. The <strong>intensive phase</strong> lasts for 2 months and four drugs are used. They are isoniazid, rifampicin, pyrazinamide, and ethambutol. The <strong>continuation phase</strong> lasts for 4 months, where isoniazid is given along with rifampicin and Ethambutol.&nbsp;</p>\n<p>After the completion of anti-tubercular treatment, the sputum/culture is tested and one of the <strong>outcomes</strong> given below is assigned to the patient:&nbsp;</p>\n<ul>\n<li><strong>Cured&nbsp;</strong>- A TB patient whose smear or culture turned negative in the last month of treatment and on at least one previous occasion&nbsp;</li>\n<li><strong>Treatment completed </strong>-<strong>&nbsp;</strong>A TB patient&nbsp;who completed treatment without any failure, but has<strong> no record</strong> to show that <strong>sputum smear</strong> or <strong>culture</strong> results in the last month of treatment and on at least one previous occasion were <strong>negative</strong>; it may be either because tests were not done or because results are unavailable</li>\n<li><strong>Treatment failed&nbsp;</strong>-&nbsp;A TB patient whose <strong>sputum smear</strong> or <strong>culture</strong> is still <strong>positive</strong> <strong>after treatment</strong> for <strong>5 months</strong> or more&nbsp;</li>\n<li><strong>Lost to follow-up&nbsp;</strong>-<strong>&nbsp;</strong>A TB patient who <strong>did not start treatment</strong> or whose <strong>treatment</strong> was <strong>interrupted</strong> for <strong>2 consecutive months</strong> or more</li>\n<li>Died -&nbsp;A TB patient who dies before starting or during the course of treatment for any reason</li>\n<li>Not evaluated - A TB patient for whom no treatment outcome is assigned; this includes cases \"transferred out\" to another treatment unit and cases for whom the treatment outcome is unknown to the reporting unit whose treatment I interrupted</li>\n</ul><hr><h3>Related Pearl: ATT Regimen for TB Patients</h3><p>As per the latest recommendations from <strong>National Tuberculosis Elimination Programme (NTEP)</strong>, treatment of TB is now based primarily on <strong>drug susceptibility testing</strong>. This is irrespective of new cases, previously treated cases or recurrent TB cases. <br />All cases of TB are treated with Drug Sensitive TB Regimen, as long as the patient is sensitive to isoniazid and rifampicin. (<strong>No classification into category I or II</strong>)</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of TB Case</strong></td>\n<td><strong>Intensive Phase</strong></td>\n<td><strong>Continuation Phase</strong></td>\n</tr>\n<tr>\n<td>New and previously treated cases (H and R sensitive)</td>\n<td>2 months H R Z E</td>\n<td>4 months H R E</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<h2><strong><span>Classification based on drug resistance. </span></strong></h2>\n<p><span>The<strong> </strong>cases are classified as:</span></p>\n<ul>\n<li><strong>Mono-resistant (MR):</strong> A TB patient, who is resistant to one 1st line anti-TB drug only.</li>\n<li><strong>Poly-Drug Resistant (PDR):</strong> A TB patient, who is resistant to more than one 1st line anti-TB drug, other than Rifampicin and isoniazid. </li>\n<li><strong>Rifampicin Resistant (RR):</strong> A TB patient, who is resistant to <strong>rifampicin</strong> with or without resistance to other drugs. Patients, who have rifampicin resistance, should be managed as if they are an MDR TB case.</li>\n<li><strong>Multi-Drug Resistant (MDR):</strong> A TB patient, who is resistant to <strong>both isoniazid and rifampicin.</strong></li>\n<li><strong>Extensively Drug-Resistant (XDR):</strong> A MDR TB patient who is additionally resistant to a <strong>fluoroquinolone</strong> (ofloxacin, levofloxacin, or moxifloxacin) and at least one additional group A drug (as of 2021, these are bedaquiline and linezolid)</li>\n</ul>\n<h2><strong><span>Standard DR TB regimen</span></strong></h2>\n<table>\n<tbody>\n<tr>\n<td><strong>Regimen class</strong></td>\n<td><strong>Drugs</strong></td>\n<td><strong>Comments</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/ poly-drug resistant TB regimen</strong></td>\n<td>Lfx R E Z for 6 months</td>\n<td>\n<p>6 months long</p>\n<p>Oral drugs only</p>\n</td>\n</tr>\n<tr>\n<td><strong>BPaLM regime (New MDR regime by WHO)</strong></td>\n<td>Bdq Pa Lzd Mfx for 6 months</td>\n<td>\n<p>6 months long</p>\n</td>\n</tr>\n<tr>\n<td><strong>9- 11 months shorter oral bedaquiline regime (Shorter MDR)</strong></td>\n<td>\n<p><strong>Intensive Phase:</strong></p>\n<p>Lfx Bdq(6 months) Cfz Z Hh E Eto for 4-6 months</p>\n<p><strong>Continuation phase:</strong></p>\n<p>Lfx Cfz Z E for 5 months</p>\n</td>\n<td>\n<p>9-11 months long totally</p>\n<p>Injectables used in Intensive phase.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Bdq(6 months or longer) Lfx Lzd Cfz Cs </td>\n<td>\n<p>18-20 months long</p>\n<p>Oral drugs only</p>\n<p>This regimen is used for XDR TB patients for 20 months.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<h2> </h2>\n<h2><strong><span>Criteria for patients to receive standard Drug Resistant TB regimen:</span></strong></h2>\n<table>\n<tbody>\n<tr>\n<td><strong>Standard Drug Resistant TB regimen</strong></td>\n<td><strong>Inclusion criteria</strong></td>\n<td><strong>Exclusion criteria</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/poly-drug resistant TB regimen</strong></td>\n<td><strong>Isoniazid resistant</strong> TB with <strong>rifampicin sensitive</strong></td>\n<td>No specific criteria</td>\n</tr>\n<tr>\n<td><strong>BPaLM regimen (New MDR TB regimen by WHO)</strong></td>\n<td>\n<ol>\n<li><strong>MDR/RR-TB</strong> or <strong>pre-XDR-TB</strong> ( MDR/RR-TB and resistance to fluoroquinolones). </li>\n<li>Those with <strong>confirmed</strong> pulmonary TB and all forms of extrapulmonary TB (except for TB involving CNS, osteoarticular, and miliary TB).</li>\n<li>Patients <strong>&gt;14 years of age.<br /></strong></li>\n</ol>\n</td>\n<td>Pregnant and lactating women</td>\n</tr>\n<tr>\n<td><strong>9- 11 months shorter MDR TB regimen</strong></td>\n<td>Patient with <strong>rifampicin resistant</strong> pulmonary or extra pulmonary TB</td>\n<td>Non drug sensitivity test based criteria:\n<ul>\n<li>Pregnancy</li>\n<li>Any extra pulmonary disease in PLHIV</li>\n<li>Disseminated meningeal or central nervous system TB</li>\n<li>Intolerance to any drug in the shorter MDR TB regimen</li>\n</ul>\nDrug sensitivity test based criteria:\n<ul>\n<li>If DST/DRT result for FQ or SLI is resistant (XDR TB)</li>\n<li>Presence of InhA mutation</li>\n<li>Resistant to Z </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Patients in whom <strong>shorter MDR TB regimen cannot be considered</strong> due to any reason</td>\n<td>None</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Legend</p>\n<p>FQ: Fluoroquinolone</p>\n<p>SLI: Second Line Injectable</p>\n<p>PLHIV: People Living with HIV</p>\n<p>Lfx: Levofloxacin</p>\n<p>Pa: Pretomanid</p>\n<p>H: Isoniazid</p>\n<p>Hh: High Dose Isoniazid</p>\n<p>R: Rifampicin</p>\n<p>E: Ethambutol</p>\n<p>Z: Pyrazinamide</p>\n<p>Mfx: Moxifloxacin</p>\n<p>Km: Kanamycin</p>\n<p>Am: Amikacin</p>\n<p>Eto: Ethionamide</p>\n<p>Cfz: Clofazimine</p>\n<p>Bdq: Bedaquiline</p>\n<p>Lzd: Linezolid</p>\n<p>Cs: Cycloserine</p><hr><h3>Related Pearl: Diagnostic algorithm for Pulmonary TB – National Tuberculosis Elimination Programme (NTEP) 2020 Guidelines</h3><p>Any case of&nbsp;<strong>presumptive pulmonary TB</strong>&nbsp;should undergo <strong>sputum examination + chest X-ray + CB-NAAT</strong></p>\n<ul>\n<li>If sputum and chest X-ray normal:<strong> rule out TB and refer</strong></li>\n<li>If sputum is positive and CB NAAT is positive:<strong>&nbsp;microbiologically confirmed case of TB</strong></li>\n</ul>\n<p>The following protocol is used for <strong>CB-NAAT testing:</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e8d17e5087654b588b4b519b350acb71x1280x2558.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5409",
      "difficulty": "medium"
    },
    {
      "text": "A cohort study was conducted with drinkers and non-drinkers of green tea to study its effect on diabetes mellitus. The risk ratio was found to be 0.84. Which of the following statements is correct?",
      "choices": [
        {
          "id": 1,
          "text": "Green tea reduces the risk of diabetes"
        },
        {
          "id": 2,
          "text": "Green tea increases the risk of diabetes"
        },
        {
          "id": 3,
          "text": "Data insufficient to establish causal association"
        },
        {
          "id": 4,
          "text": "The value (0.85) tends to be close to 1, hence there is no effect"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Green tea reduces the risk of diabetes mellitus</strong>&nbsp;is the correct statement since the <strong>risk ratio is 0.84.</strong></p>\n<p><strong>Relative risk</strong>&nbsp;(RR) or&nbsp;<strong>risk ratio</strong>&nbsp;is the ratio of the incidence of the disease (or death) among exposed and the incidence among non-exposed. It can be determined from a<strong> cohort study.&nbsp;</strong></p>\n<p>It is a direct measure of the&nbsp;<strong>strength of the association</strong>&nbsp;between suspected cause and effect. The larger the RR, the greater the strength of the association between the suspected factor and disease.&nbsp;</p>\n<ul>\n<li>RR &lt; 1 indicates inverse association(protective effect).</li>\n<li>RR = 1 indicates no association</li>\n<li>RR &gt; 1 indicates a positive association.</li>\n<li>RR of 2 indicates a 100% increase in risk.</li>\n</ul>\n<p>&nbsp;In the question, the risk ratio is less than 1. Hence it implies the incidence of diabetes mellitus is reduced when exposed to green tea.&nbsp;</p><hr><h3>Related Pearl: Relative and Attributable Risk</h3><p>Relative Risk:</p>\n<ul>\n<li>Ratio of incidence of disease or death among exposed to that among the non-exposed is called <strong>relative risk (RR).</strong></li>\n<li>It is also called <strong>risk ratio</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f8f2d7bcf01a465699a42d1a750c87b8x1280x704.JPEG\" alt=\"Pearl Image\"><ul>\n<li>It is the direct measure of the <strong>strength of association</strong> between suspected cause and effect in <strong>cohort studies</strong>.</li>\n<li>RR &lt; 1 indicates inverse association(protective effect)</li>\n<li>RR = 1 indicates no association.</li>\n<li>RR &gt; 1 indicates positive association.</li>\n<li>RR of 2 indicates a 100% increase in risk.</li>\n<li>Relative risk calculation (RR) = [ a/(a+b) ]/ [ c/(c+d) ] where, </li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td colspan=\"3\">Cancer</td>\n</tr>\n<tr>\n<td rowspan=\"3\">Exposure</td>\n<td> </td>\n<td>yes</td>\n<td>no</td>\n</tr>\n<tr>\n<td>yes</td>\n<td>a</td>\n<td>b</td>\n</tr>\n<tr>\n<td>no</td>\n<td>c</td>\n<td>d</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p>Attributable Risk:</p>\n<ul>\n<li><strong>Attributable risk (AR)</strong> is the <strong>difference</strong> in incidence rates or proportions of disease or death between an exposed and non-exposed group.</li>\n<li>It is expressed in <strong>percentage</strong> and gives the extent to which the disease can be attributed to the exposure in a <strong>cohort study.</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c96f4beb9eb942899198d757d3388918x1280x904.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Cohort Study</h3><ul>\n<li>A <strong>cohort study</strong> progresses from <strong>cause</strong> (exposure) <strong>to effect</strong> (disease).</li>\n<li>It is also known as <strong>forward-looking </strong>study, <strong>incidence </strong>study,<strong> prospective </strong>study, and<strong> longitudinal </strong>study.</li>\n<li><strong>Design of a cohort study:</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2ea236bdd083460eaa50179f47f0948dx1280x1373.JPEG\" alt=\"Pearl Image\"><ul>\n<ul>\n<li><strong>Types of cohort study:</strong>\n<ul>\n<li>Prospective (concurrent) cohort studies</li>\n<li>Retrospective (historical) cohort studies</li>\n<li>Combination cohort studies</li>\n</ul>\n</li>\n<li><strong>Steps of cohort study:</strong>\n<ul>\n<li>Selection of study subjects</li>\n<li>Obtaining data on exposure</li>\n<li>Selection of comparison groups</li>\n<li>Follow-up</li>\n<li>Analysis in terms of incidence rates and estimation of risk</li>\n</ul>\n</li>\n<li><strong>Advantages of cohort study:</strong>\n<ul>\n<li>Incidence can be calculated</li>\n<li>Several possible outcomes related to exposure can be studied at the same time</li>\n<li>Provides direct estimate of relative risk</li>\n<li>Calculation of dose-response ratio</li>\n<li>Minimization of certain biases</li>\n</ul>\n</li>\n<li><strong>Disadvantages of cohort study:</strong>\n<ul>\n<li>Cannot use for uncommon diseases</li>\n<li>Expensive, requires a large population and&nbsp;longer time</li>\n<li>Many common administrative and ethical problems</li>\n<li>High attrition and selection of subjects is difficult</li>\n<li>Dynamism of diagnostics is difficult to incorporate</li>\n<li>Tends to alter the behaviour of subjects known as&nbsp;<strong>Hawthorne effect</strong>.</li>\n</ul>\n</li>\n</ul>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5324",
      "difficulty": "easy"
    },
    {
      "text": "Which statement refers best to the criteria for starting an urban community health center?",
      "choices": [
        {
          "id": 1,
          "text": "Caters to a population of 1-1.5 lakh"
        },
        {
          "id": 2,
          "text": "Referral centre for 2- 3 primary health centers"
        },
        {
          "id": 3,
          "text": "No sub-district and district hospitals present in the area"
        },
        {
          "id": 4,
          "text": "Should have a 100-bed facility in metro cities"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>An <strong>urban</strong> <strong>community health center </strong>(U-CHC)&nbsp;has a <strong>100-bed facility in metro cities.&nbsp;&nbsp;</strong><strong>&nbsp;</strong></p>\n<p>U-CHC acts as a <strong>referral center</strong> for&nbsp;<strong>4&ndash;5 urban primary health centers (U-PHC)</strong>. It is usually a 30&ndash;50 bedded facility that caters to a <strong>population</strong> of<strong> 2,50,000</strong>.&nbsp;</p>\n<p>When it comes to<strong> metro cities,</strong>&nbsp;it caters to a population of<strong> 5,00,000</strong> with a <strong>100-bed facility</strong>. These hospitals will have surgeons, gynecologists, physicians, and pediatricians, along with x-ray and laboratory facilities.&nbsp;</p>\n<p>The specialists at the community health center can refer a patient to the state-level hospital or the nearest medical college hospital directly. The<strong> subdistrict</strong> and <strong>district hospitals</strong> operate <strong>in addition</strong> to CHC to cater to the population.&nbsp;&nbsp;</p>\n<p>Services of CHC:</p>\n<ul>\n<li>Care of routine and emergency cases in medicine and surgery</li>\n<li>Maternal, newborn, and child health</li>\n<li>Family planning</li>\n<li>All the national health program functions</li>\n<li>Physical medicine and rehabilitation services</li>\n</ul><hr><h3>Related Pearl: Community Health Centre Human Resources</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Personnel</strong></p>\n</td>\n<td>\n<p><strong>Strength (Essential)</strong></p>\n</td>\n<td>\n<p><strong>Desirable Qualifications</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Block Medical Officer</p>\n</td>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Senior most specialist</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Public Health Specialist</p>\n</td>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>MD/MBA/MPH/DPH</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Public Health Nurse</p>\n</td>\n<td>\n<p>1</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>General surgeon</p>\n</td>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>MS/DNB</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Physician</p>\n</td>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>MD/DNB</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>OG-cian</p>\n</td>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>MD/DNB/DGO</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Paediatrician</p>\n</td>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>MD/DNB/DCH</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anesthetist</p>\n</td>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>MD/DNB/DA/LSAS trained MO</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dental surgeon</p>\n</td>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>BDS</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>General Duty MO</p>\n</td>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>MBBS</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>AYUSH Medical Officer</p>\n</td>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Graduate in AYUSH</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ophthalmologist</p>\n</td>\n<td>\n<p>1 for 5 CHCs</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Staff Nurse</p>\n</td>\n<td>\n<p>10</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Pharmacist</p>\n</td>\n<td>\n<p>2</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Lab. Technician</p>\n</td>\n<td>\n<p>2</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Radiographer</p>\n</td>\n<td>\n<p>1</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Assistants</p>\n</td>\n<td>\n<p>2</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Cold Chain assistant</p>\n</td>\n<td>\n<p>1</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>OT technician</p>\n</td>\n<td>\n<p>1</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Counselor</p>\n</td>\n<td>\n<p>1</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Rehabilitation worker</p>\n</td>\n<td>\n<p>1</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Other admin staff</p>\n</td>\n<td>\n<p>6</p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Group D staff</p>\n</td>\n<td>\n<p>7</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Total</strong></p>\n</td>\n<td>\n<p>46</p>\n</td>\n<td>\n<p>Ophthalmologist not included</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Sub-centre vs. PHC vs. CHC</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>HWC-Sub centre</td>\n<td>HWC-Primary Health Centre (PHC)</td>\n<td>Community Health Centre (CHC)</td>\n</tr>\n<tr>\n<td>Healthcare level</td>\n<td>Primary</td>\n<td>Primary</td>\n<td>Secondary</td>\n</tr>\n<tr>\n<td>\n<p>Population norm</p>\n<p>Plain areas</p>\n<p>Hilly or remote areas</p>\n<p>Urban areas</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>1 per 5000</p>\n<p>1 per 3000</p>\n<p>UHWC- 1 per 15000-20000</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>1 per 30,000</p>\n<p>1 per 20,000</p>\n<p>1 per 50,000, 1 per 2.5-3 lakh (polyclinic)</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>1 per 1,20,000</p>\n<p>1 per 80,000</p>\n<p>1 per 5 lakh (metro cities), 1 per 2.5 lakh (non-metro cities)</p>\n</td>\n</tr>\n<tr>\n<td>Total essential staff</td>\n<td>\n<p>HWC-SHC- 4 (including 1 ASHA)</p>\n<p>UHWC- 6 (including 1 ASHA)</p>\n</td>\n<td>\n<p>PHC: 12</p>\n<p>UPHC:16</p>\n<p>24X7 PHC: 23</p>\n<p>24X7 UPHC: 27</p>\n<p>Polyclinic: 22</p>\n</td>\n<td>\n<p>Non-FRU CHC: 33</p>\n<p>FRU CHC: 52 (30 beds), 56 (50 beds)</p>\n<p>FRU-UCHC: 55 (50 beds), 72 (100 beds)</p>\n</td>\n</tr>\n<tr>\n<td>Number of beds</td>\n<td>0</td>\n<td>\n<p>HWC-PHC- 2HWC UPHC: 2 (daycare)</p>\n<p>24X7 HWC-PHC/UPHC: 6</p>\n</td>\n<td>\n<p>Non-FRU CHC: 30</p>\n<p>FRU CHC: 30/50</p>\n<p>FRU-UCHC: 50/100</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>HWC- Health and wellness centre</p>\n<p>FRU- First referral unit</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5302",
      "difficulty": "medium"
    },
    {
      "text": "How is a broken vaccine vial disposed, according to biomedical waste management?",
      "choices": [
        {
          "id": 1,
          "text": "Puncture proof blue bin"
        },
        {
          "id": 2,
          "text": "White container"
        },
        {
          "id": 3,
          "text": "Yellow container"
        },
        {
          "id": 4,
          "text": "Red container"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>A <strong>broken vaccine vial</strong> is disposed of in a <strong>puncture-proof blue bin, </strong>according to <strong>biomedical waste management </strong>(BMW).<strong> </strong></p>\n<p>According to BMW, broken or discarded contaminated <strong>glass materials</strong> such as <strong>vials</strong>, ampules, etc are disposed of in boxes marked with <strong>blue color</strong>. It is then <strong>disinfected </strong>either by washing with detergent, autoclaving, or microwaving and sent for recycling. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/955feb4d376a48b09a4a7c7336ec9046x720x558.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/677a8692eede4111ad442e1e257bd814x1280x782.JPEG\" alt=\"Explanation Image\"><p> </p>\n<p>The methods used for <strong>treatment and disposal</strong> of healthcare waste are:</p>\n<ul>\n<li><strong>Incineration:</strong> This is a dry oxidation process done using high temperatures.</li>\n<li><strong>Chemical disinfection</strong>: Chemicals are added to waste to kill or inactivate the microorganisms.</li>\n<li><strong>Wet and dry thermal treatment</strong>: Shredded infectious waste is exposed to high temperature, high-pressure steam and it resembles an autoclave sterilization process. </li>\n<li><strong>Microwave irradiation: </strong>Microorganisms are killed using high-frequency microwave.</li>\n<li><strong>Land disposal.</strong></li>\n<li><strong>Inertization:</strong> Waste<strong> </strong>is mixed with cement and other substances before disposal to reduce toxicity. </li>\n</ul><hr><h3>Related Pearl: Biomedical waste disposal</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><span><strong>&nbsp;<span> Yellow bag </span></strong><strong><span>(non-chlorinated)</span></strong><strong><span>&nbsp;</span>&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type of Waste</p>\n</td>\n<td>&nbsp;Treatment and Disposal Options</td>\n</tr>\n<tr>\n<td>\n<p><strong>Human anatomical waste</strong></p>\n<p><strong>Animal anatomical waste</strong></p>\n</td>\n<td>\n<p><strong>Incineration</strong>/Plasma pyrolysis/Deep Burial</p>\n</td>\n</tr>\n<tr>\n<td><strong>Soiled Waste: </strong>Items like dressings, cotton swabs, and plaster casts contaminated with blood and body fluids and bags containing residual discarded blood.</td>\n<td>\n<p><strong>Incineration</strong>/Plasma pyrolysis/Deep Burial</p>\n<p>or</p>\n<p>Autoclaving/Microwaving/ Hydroclaving</p>\n<p>Later - Shredding/mutilation</p>\n</td>\n</tr>\n<tr>\n<td>Discarded linen, mattresses, beddings contaminated with blood or body fluid,<strong> routine masks, and gowns</strong></td>\n<td>\n<p>Non- chlorinated chemical disinfection<br />followed by incineration or Plazma<br />Pyrolysis or for energy recovery.<br />In absence of the above facilities, shredding,&nbsp;mutilation, or a combination of&nbsp;sterilization and shredding is used.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Microbiology, biotechnology, clinical laboratory waste</strong></p>\n<p>(Autoclave safe plastic bags used)</p>\n<p><strong>Blood bags</strong>, laboratory<br />cultures, stocks or&nbsp;specimens of microorganisms,<br />live or&nbsp;attenuated vaccines,&nbsp;human and animal cell&nbsp;cultures used in&nbsp;research, industrial&nbsp;laboratories, production&nbsp;of biological, residual&nbsp;toxins, dishes, and&nbsp;devices used for&nbsp;cultures.</p>\n</td>\n<td>\n<p>Pre-treatment with nonchlorinated chemicals</p>\n<p>Later - Incineration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Expired/discarded medicine, cytotoxic drugs</p>\n</td>\n<td>Incineration/plasma pyrolysis/ disposal in a secured landfill</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p><strong>Chemical waste</strong></p>\n<p>Chemicals used in biological production&nbsp;and used or discarded<br />disinfectants.</p>\n</td>\n<td>\n<p>Disposal- incineration/plasma<br />pyrolysis</p>\n<p>Encapsulation-&nbsp;hazardous waste treatment, storage, and&nbsp;disposal facility.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Chemical liquid</strong>&nbsp;<strong>waste</strong> :<br />Liquid waste generated&nbsp;due to the use of chemicals&nbsp;in the production of<br />biological and used or&nbsp;<strong>discarded disinfectants,</strong>&nbsp;silver X-ray film<br />developing liquid,<br />discarded formalin,<br />infected <strong>secretions,</strong><br /><strong>aspirated body&nbsp;fluids</strong>,&nbsp;liquid from&nbsp;laboratories and floor&nbsp;washings, cleaning,&nbsp;house-keeping and<br />disinfecting activities&nbsp;etc.</p>\n<p>&nbsp;</p>\n</td>\n<td>After resource recovery, the chemical<br />liquid waste shall be pre-treated before&nbsp;mixing with other wastewater.&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><span><strong>&nbsp; Red&nbsp;bag (non-chlorinated)&nbsp;&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td><strong>&nbsp;Type of Waste</strong></td>\n<td>\n<p><strong>&nbsp;<span>Treatment and Disposal Options</span></strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Recyclable contaminated</strong> waste</p>\n<p>Contaminated waste tubing, bottles, intravenous tubes and sets, <strong>catheters,</strong> <strong>urine bags</strong>, syringes (without needles and fixed needle syringes with their needles cut), <strong>vacutainers with</strong> <strong>needles cut,</strong> and gloves.</p>\n</td>\n<td>\n<p><strong>Autoclaving/Microwaving/<br />Hydroclaving</strong></p>\n<p>Followed by Shredding/mutilation</p>\n<p>And later, Energy recovery/Plastics to diesel or fuel oil/road-making</p>\n<p>Not to be sent to landfill</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><strong>&nbsp; White (translucent)&nbsp;&nbsp;<br />(puncture-proof, leak-proof containers)</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Type of Waste</strong></td>\n<td>\n<p><strong>Treatment and Disposal Options</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Waste Sharps including metals.</strong></p>\n<p>Needles, syringes with fixed needles, needles from needle tip cutter or burner, scalpels, blades, or any other <strong>contaminated sharp</strong> object that may cause puncture and cuts. This includes both used, discarded, and contaminated metal sharps</p>\n</td>\n<td>\n<p>Autoclaving/ Dry heat sterilization</p>\n<p>Followed by - <strong>Shredding/mutilation</strong>/<br />encapsulation</p>\n<p>Later by - Iron foundries/sanitary landfill/waste sharps</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p>&nbsp;<span><strong><span>&nbsp; Blue&nbsp;&nbsp;</span><br /></strong></span><span><strong><span>(Puncture proof and leak proof containers with blue colored marking)</span></strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type of Waste&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;Treatment and Disposal Options</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glassware</strong></p>\n<p>Broken or discarded and contaminated glass including medicine <strong>vials</strong> and <strong>ampules except</strong> those containing <strong>cytotoxic</strong> waste.</p>\n<p><strong>Metallic body implants</strong></p>\n</td>\n<td>\n<p>Sodium hypochlorite/Autoclaving/<br />Microwaving/Hydroclaving</p>\n<p>Later - Recycling</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>&nbsp;Note: <strong>Ash</strong> from the <strong>incineration</strong> of biomedical waste shall be disposed of at a <strong>common hazardous waste treatment and disposal facility</strong>. However, it may also be disposed of in a <strong>municipal landfill</strong>, <strong>if</strong> the toxic metals in incineration ash are <strong>within</strong> the <strong>regulatory quantities</strong> as defined under the Hazardous Waste (Management and Handling and Transboundary Movement) Rules, 2008 as amended from time to time.</p><hr><h3>Related Pearl: Biomedical Waste (BMW) Management -COVID 19</h3><p>In addition to the current BMW Management rules, the following measures are proposed</p>\n<ul>\n<li>To report opening/operation of COVID 19 Ward/ICU/Lab/Collection Centre to <strong>SPCB</strong> (State Pollution Control Board) and <strong>CBWTF</strong> (Common Biomedical Waste Treatment Facility) in that area</li>\n<li>Dedicated sanitation workers deputed only to collect COVID 19 BMW</li>\n<li>It is mandatory for all BMW bags and containers from COVID 19 areas to carry <strong>\"COVID 19 WASTE\"</strong> label</li>\n<li>Keep separate colour coded bins with <strong>foot operated lids</strong></li>\n<li>The inner and outer surfaces of these containers must be disinfected daily with <strong>1% sodium hypochlorite</strong> solution</li>\n<li>To ensure no leaks, <strong>double layers&nbsp;</strong>(2 bags) are used</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>COLOUR OF THE BIN</strong></td>\n<td><strong>PERSONAL PROTECTIVE EQUIPMENT(PPE)</strong></td>\n<td><strong>OTHER WASTE</strong></td>\n</tr>\n<tr>\n<td><strong>Red Bin</strong></td>\n<td>\n<ul>\n<li>Goggles</li>\n<li>Face shield&nbsp;</li>\n<li>Splash-proof apron</li>\n<li>Plastic coverall</li>\n<li>Hazmat suit</li>\n<li>Nitrile gloves</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Used gloves</li>\n</ul>\n<p><strong>Laboratory waste</strong></p>\n<ul>\n<li>Pre-treated viral transport media</li>\n<li>Plastic vials and cryovials</li>\n<li>Vacutainers</li>\n<li>Eppendorf tubes</li>\n<li>Pipette tips</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Yellow Bin</strong></td>\n<td>\n<ul>\n<li>Used mask(triple layer mask, N95 mask)</li>\n<li>Head cover/Cap, Shoe cover</li>\n<li>Disposable linen gown&nbsp;</li>\n<li>Non-plastic/Semi-plastic coverall</li>\n</ul>\n</td>\n<td>\n<p>&nbsp;</p>\n<ul>\n<li>Diapers with feces of immobile COVID 19 patients&nbsp;</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5296",
      "difficulty": "medium"
    },
    {
      "text": "In an urban area in the state of Madhya Pradesh, a primigravida goes for institutional delivery after being motivated by an ASHA worker. What are the benefits they will receive (in terms of money in rupees) under the Janani Suraksha Yojana?<div class='question-desc-html'><p>ASHA- Accredited social health activist</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "1000 for mother and 400 for ASHA"
        },
        {
          "id": 2,
          "text": "1400 for mother and 600 for ASHA"
        },
        {
          "id": 3,
          "text": "600 for mother and 400 for ASHA"
        },
        {
          "id": 4,
          "text": "400 for mother and 600 for ASHA"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>According to<strong> Janani Suraksha Yojana (JSY) </strong>scheme, the <strong>mother </strong>will receive<strong> 1000 rupees</strong> and the <strong>ASHA worker</strong> will receive <strong>400 rupees.</strong></p>\n<p>Janani Suraksha Yojana (JSY) is a program under the National Rural Health Mission (NRHM),<strong> </strong>whose aim is to <strong>reduce maternal mortality</strong> by encouraging <strong>delivery</strong> in<strong> government health facilities</strong>. Under the scheme, a financial incentive is also provided for giving birth in a government health facility. </p>\n<p>The <strong>Accredited Social Health Activist </strong>(ASHA)<strong> </strong>is the link between pregnant women and health institutions. She is responsible for making institutional antenatal and postnatal care available. </p>\n<p>States are divided into low-performing and high-performing on the basis of <strong>institutional delivery rate</strong>. The 10 low-performing states (LPS) with a low institutional delivery rate are Uttar Pradesh, Uttarakhand, Madhya Pradesh, Jharkhand, Bihar, Rajasthan, Chattisgarh, Odisha, Assam, and Jammu &amp; Kashmir. All the other states are high-performing states (HPS).</p>\n<p>The incentives under JSY are as follows:</p>\n<table>\n<tbody>\n<tr>\n<td>Category </td>\n<td>Rural area</td>\n<td><strong>Urban area</strong></td>\n</tr>\n<tr>\n<td>LPS</td>\n<td>\n<p>Mother package: 1400/-<br />ASHA's package:600/-<br />Total:2000/-</p>\n</td>\n<td><strong>Mother package: 1000/-</strong><br /><strong>ASHA's package:400/-</strong><br />Total:1400/-</td>\n</tr>\n<tr>\n<td>HPS</td>\n<td>Mother package: 700/-<br />ASHA's package:600/-<br />Total:1300/-</td>\n<td>Mother package: 600/-<br />ASHA's package:400/-<br />Total:1000/-</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Under this scheme, the cost of cesarean section and management of obstetric complications is also subsidized, up to <strong>Rs 1500</strong> per delivery to the government institutions, where government specialists are not present.</p><hr><h3>Related Pearl: ASHA</h3><p>ASHA stands for&nbsp;<strong>Accredited Social Health Activist.</strong></p>\n<p>General norms with respect to ASHA workers:</p>\n<ul>\n<li>Must be a <strong>woman</strong>&nbsp;in the age group of 25-45 years -&nbsp;married/divorced/widow</li>\n<li>Must be a <strong>resident</strong> of that village</li>\n<li>Formal education of up to <strong>10<sup>th</sup> standard&nbsp;</strong>\n<ul>\n<li>If no candidates are available, the requirement can be relaxed to the 8<sup>th</sup> standard</li>\n</ul>\n</li>\n<li>At least <strong>1 ASHA</strong> for a <strong>population of 1000&nbsp;</strong>\n<ul>\n<li>In tribal, hilly, and desert areas, the norm can be relaxed to 1 ASHA per habitation</li>\n</ul>\n</li>\n</ul>\n<p>States can relax the norms on population and educational qualifications on a case-to-case basis, depending on the local conditions. However, these are exceptions and not the general norm.</p>\n<p><strong>Responsibilities </strong>of ASHA:</p>\n<ul>\n<ul>\n<li>Health <strong>education</strong> and awareness</li>\n<li><strong>Reproductive and child health</strong> and family planning</li>\n<li>Facilitate the access to health services</li>\n<li>Promotion of <strong>sanitation</strong> and household toilet construction</li>\n<li>Provision of primary medical care for <strong>minor ailments</strong></li>\n<li>Provider of <strong>DOTS</strong></li>\n<li><strong>Depot holder</strong> of essentials like ORS, iron and folic acid tablets, condoms, disposable delivery kits, etc.</li>\n<li>Dispersal of <strong>health information</strong> on her community to higher centres</li>\n<li>Some responsibilities are integrated with Anganwadi workers and Auxiliary Nurse Midwife</li>\n</ul>\n</ul>\n<p>Home visits by ASHA under Home-based Newborn care (HBNC)&nbsp;</p>\n<ul class=\"p-rich_text_list p-rich_text_list__bullet\" data-stringify-type=\"unordered-list\" data-indent=\"0\" data-border=\"0\">\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\"><strong>7 visits</strong> after <strong>home delivery</strong> (on days 1, 3, 7, 14, 21, 28 and 42)</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\"><strong>6 visits</strong> after <strong>institutional delivery</strong> (on days 3, 7, 14, 21, 28 and 42) in case of a <strong>vaginal delivery</strong>; and <strong>5 visits</strong> in cases of <strong>Caesarean section</strong> delivery, where the mother returns home after 5-6 days, i.e, on days - 7, 14, 21, 28 and 42.</li>\n</ul>\n<p>Home visits by ASHA under Home-based care of young child (HBYC)</p>\n<ul>\n<li>A total of&nbsp;<strong>5 visits</strong>&nbsp;are scheduled&nbsp;<strong>after 42 days</strong>&nbsp;under the&nbsp;<strong>Home-Based Care of the Young Child(HBYC).</strong></li>\n<li>ASHA will provide <strong>quarterly home visits</strong> on the 3rd, 6th, 9th, 12th and 15th months</li>\n</ul><hr><h3>Related Pearl: Maternal Mortality Ratio</h3><p><strong>Maternal death</strong> is defined as the death of a woman <strong>while pregnant or within 42 days of termination of pregnancy</strong>, irrespective of the duration and site of pregnancy, from <strong>any cause related to or aggravated by the pregnancy</strong> or its management but not from accidental or incidental causes.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/19493f9439a24b529b7a098cbbce594cx1280x644.JPEG\" alt=\"Pearl Image\"><p>The main global causes of maternal deaths are <strong>severe bleeding, indirect causes</strong> (anemia, malaria, heart diseases), <strong>infections, unsafe abortions, eclampsia, obstructed labor,</strong> and other direct causes like ectopic pregnancy, anesthesia-related complications, etc.</p>\n<p>In India, the most common causes of maternal deaths are hemorrhage (leading cause), sepsis, obstructed labor, hypertensive disorders, etc.</p><hr><h3>Related Pearl: Neonatal Mortality Rate</h3><ul>\n<li><strong>Neonatal deaths</strong> are those that occur during the neonatal period, commencing at birth and ending at 28 completed days after birth.</li>\n<li><strong>NMR = Number of deaths of children under 28 days of age in a year x 1000/Total live births in the same year</strong></li>\n<li>Main causes of neonatal death are <strong>prematurity&nbsp;</strong>(leading cause), birth asphyxia, intrapartum-related complications, sepsis, pneumonia, congenital anomalies, tetanus, diarrhea, etc.</li>\n<li>India&rsquo;s NMR&nbsp; is<strong>&nbsp;20 per 1000 live births&nbsp;</strong>(SRS 2020)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5291",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following agency provides seed and manure in applied nutrition programs in schools?",
      "choices": [
        {
          "id": 1,
          "text": "CARE"
        },
        {
          "id": 2,
          "text": "UNDP"
        },
        {
          "id": 3,
          "text": "UNICEF"
        },
        {
          "id": 4,
          "text": "WHO"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>UNICEF&nbsp;</strong>provides seed and manure in applied nutrition programs in schools.&nbsp;</p>\n<p><strong>Applied Nutrition Program&nbsp;</strong>is implemented with the aim of producing various types of productive food by the community for the community itself.</p>\n<p><strong>UNICEF</strong> assists the program by providing implements, <strong>seeds, manure, </strong>and&nbsp;water supply equipment. If free land is available in <strong>schools,&nbsp;</strong>the facilities provided by UNICEF should be used in developing school gardens.</p>\n<p>The produce obtained from the gardens can be utilized for<strong> school feeding programs</strong> and for nutrition education.&nbsp;</p>\n<p>Another strategy called&nbsp;<strong>GOBI&nbsp;</strong>was also implemented by UNICEF with the aim of a <strong>child health revolution.&nbsp;</strong></p>\n<p>Other options:</p>\n<p>Option A- <strong>CARE</strong>-&nbsp;Cooperative for Assistance and Relief Everywhere aims at<strong> providing food</strong> for children in the age group of 6-11 years. It is also helping in projects like&nbsp;integrated nutrition and health project, better health and nutrition projects, anemia control projects, etc.</p>\n<p>Option B- <strong>UNDP</strong>-&nbsp;The United Nations Development Program provides funds for <strong>technical assistance.</strong>&nbsp;Its main objective is to help poorer nations in developing their human and natural resources.&nbsp;</p>\n<p>Option D-<strong> WHO-</strong>&nbsp;World Health Organization aims at the attainment of the <strong>highest level of health</strong> by all people, which helps them to lead a socially and economically productive life.&nbsp;</p><hr><h3>Related Pearl: Organizations and their Headquarters</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/711a91acb3c244ec80d64252f8ba6ce1x468x435.PNG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/28903e978b2744c7b00bed32612fe153x720x454.PNG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: GOBI–FFF Strategy</h3><p>This strategy was proposed by the United Nations Children&rsquo;s Fund (UNICEF)</p>\n<ul>\n<li><strong>G </strong>&ndash; Growth monitoring with growth charts</li>\n<li><strong>O </strong>&ndash; Oral rehydration therapy for diarrhoea and dehydration</li>\n<li><strong>B</strong> &ndash; Breastfeeding</li>\n<li><strong>I</strong> &ndash; Immunization of children</li>\n<li><strong>F</strong> &ndash; Family planning and birth spacing</li>\n<li><strong>F </strong>&ndash; Food supplementation</li>\n<li><strong>F </strong>&shy;&ndash; Female literacy promotion</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5287",
      "difficulty": "medium"
    },
    {
      "text": "Many children from a particular community coming to a hospital were detected to have acute lymphoblastic leukemia (ALL). It was assumed that it is due to the presence of cytotoxic waste in the water of that community. If a case-control study has to be done to find whether the chemical and ALL are associated, what will be taken as the control?",
      "choices": [
        {
          "id": 1,
          "text": "Children from the area exposed, but unaffected with the disease"
        },
        {
          "id": 2,
          "text": "Children from the area not exposed and affected with the disease"
        },
        {
          "id": 3,
          "text": "Children coming to your OPD, who do not have the disease"
        },
        {
          "id": 4,
          "text": "All children with ALL irrespective of exposure status"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Children coming to the OPD, who do not have the disease,&nbsp;</strong>will be taken as the&nbsp;<strong>control&nbsp;</strong>for the <strong>case-control study.&nbsp;</strong></p>\n<p>The prerequisite for selecting a&nbsp;<strong>control</strong>&nbsp;<strong>group</strong> is that they must be <strong>free from the disease</strong> under study. They must be as similar as possible to the cases, except for the fact that they should not have the disease.&nbsp;Usually, the control group consists of persons who <strong>have not been exposed</strong> to the disease or factor whose influence is under study. Therefore, among the options, the best answer would be the&nbsp;<strong>children</strong> <strong>coming to the OPD</strong>, <strong>who do not have the disease</strong>&nbsp;as&nbsp;<strong>controls</strong> for the study.</p>\n<p><strong class=\"ng-binding\">Case-control studies&nbsp;</strong>are also called&nbsp;<strong>retrospective</strong>&nbsp;<strong>studies.</strong>&nbsp;This study proceeds from&nbsp;<strong>effect to cause</strong>&nbsp;and is done after the exposure and outcome have occurred.</p>\n<p>They focus on diseases or health problems that have already developed. They are less time-consuming and have no risk of attrition because they&nbsp;<strong>do not require follow-up</strong>.</p>\n<p class=\"p1\">There are four basic steps in conducting a case-control study:</p>\n<ul>\n<li><strong>Selection of cases and controls.</strong></li>\n<li><strong>Matching</strong>- This is done to ensure comparability between cases and controls. Controls are selected such that they are similar to cases with respect to certain factors, like age, that influence the disease outcome.</li>\n<li><strong>Measurement of exposure -&nbsp;</strong>This is<strong>&nbsp;</strong>obtained by interviews, questionnaires, or study of the past records of cases.</li>\n<li><strong>Analysis</strong>&nbsp;in the form of exposure rates, risk ratio, and odds ratio.</li>\n</ul>\n<p class=\"p1\">The <strong>Odds Ratio</strong> (OR) calculated from a case-control study, is a measure of the&nbsp;<strong>strength of the association</strong>&nbsp;between risk factor and outcome.</p><hr><h3>Related Pearl: Case Control Study</h3><p>In a <strong>case-control</strong> study, progression is from <strong>effect </strong>(disease) to<strong> cause</strong>&nbsp;(exposure) as the outcome or disease has already occurred. It is also called a&nbsp;<strong>retrospective</strong> study.</p>\n<p><strong>Design </strong>of case-control study:</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/54361314f5e0423d9bef0e4acae144a0x1280x1242.JPEG\" alt=\"Pearl Image\"><ul>\n<li><strong>Steps of case control study:</strong>\n<ul>\n<li>Selection of cases and controls</li>\n<li>Matching</li>\n<li>Measurement of exposure</li>\n<li>Analysis in the form of exposure rates, risk ratio, and odds ratio</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Advantages of case control study:</strong>\n<ul>\n<li>Easy to carry out, rapid and inexpensive</li>\n<li>Requires few subjects, no risk to subjects</li>\n<li>Used to investigate rare diseases</li>\n<li>Different etiological factors can be studied and risk factors can be identified</li>\n<li>No attrition problems, minimal ethical problems</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Disadvantages&nbsp;of case control study:</strong>\n<ul>\n<li>Relies on memory or past records giving rise to bias</li>\n<li>Selection of appropriate control groups is difficult</li>\n<li>Incidence cannot be measured</li>\n<li>Does not distinguish between causes and associated factors</li>\n<li>Not suited for evaluation of therapy or prophylaxis</li>\n<li>Representativeness of the cases and controls is often inadequate</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Odds Ratio</h3><ul>\n<li>Odds ratio is a measure of the <strong>strength of association</strong> between<strong> risk factor</strong> and <strong>outcome</strong> in case control studies.</li>\n<li>Odds ratio can be arrived at from <strong>case control studies</strong>.</li>\n<li>It is also known as <strong>cross product ratio</strong>.</li>\n<li>A representation of the odds ratio <strong>(OR) </strong>is given in the picture below:</li>\n</ul>\n<p>Calculation of odds ratio (OR) = (a/b)/(c/d) = ad/bc where,&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td colspan=\"3\">Cancer</td>\n</tr>\n<tr>\n<td rowspan=\"3\">Exposure</td>\n<td>&nbsp;</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Yes</td>\n<td>a</td>\n<td>b</td>\n</tr>\n<tr>\n<td>No</td>\n<td>c</td>\n<td>d</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><ul>\n<li><strong>OR &lt; 1</strong> indicates <strong>possible protection</strong>&nbsp;(<strong>negative</strong> association) as the frequency of exposure is lower among cases than controls.</li>\n<li><strong>OR = 1&nbsp;</strong>indicates <strong>no association</strong> of risk with exposure, or that the event is equally likely in both groups.</li>\n<li><strong>OR &gt; 1</strong> indicates <strong>increased risk</strong>&nbsp;(<strong>positive</strong> association) as the frequency of exposure is greater among cases than controls.</li>\n</ul><hr><h3>Related Pearl: Cohort Study</h3><ul>\n<li>A <strong>cohort study</strong> progresses from <strong>cause</strong> (exposure) <strong>to effect</strong> (disease).</li>\n<li>It is also known as <strong>forward-looking </strong>study, <strong>incidence </strong>study,<strong> prospective </strong>study, and<strong> longitudinal </strong>study.</li>\n<li><strong>Design of a cohort study:</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2ea236bdd083460eaa50179f47f0948dx1280x1373.JPEG\" alt=\"Pearl Image\"><ul>\n<ul>\n<li><strong>Types of cohort study:</strong>\n<ul>\n<li>Prospective (concurrent) cohort studies</li>\n<li>Retrospective (historical) cohort studies</li>\n<li>Combination cohort studies</li>\n</ul>\n</li>\n<li><strong>Steps of cohort study:</strong>\n<ul>\n<li>Selection of study subjects</li>\n<li>Obtaining data on exposure</li>\n<li>Selection of comparison groups</li>\n<li>Follow-up</li>\n<li>Analysis in terms of incidence rates and estimation of risk</li>\n</ul>\n</li>\n<li><strong>Advantages of cohort study:</strong>\n<ul>\n<li>Incidence can be calculated</li>\n<li>Several possible outcomes related to exposure can be studied at the same time</li>\n<li>Provides direct estimate of relative risk</li>\n<li>Calculation of dose-response ratio</li>\n<li>Minimization of certain biases</li>\n</ul>\n</li>\n<li><strong>Disadvantages of cohort study:</strong>\n<ul>\n<li>Cannot use for uncommon diseases</li>\n<li>Expensive, requires a large population and&nbsp;longer time</li>\n<li>Many common administrative and ethical problems</li>\n<li>High attrition and selection of subjects is difficult</li>\n<li>Dynamism of diagnostics is difficult to incorporate</li>\n<li>Tends to alter the behaviour of subjects known as&nbsp;<strong>Hawthorne effect</strong>.</li>\n</ul>\n</li>\n</ul>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5285",
      "difficulty": "hard"
    },
    {
      "text": "An auxiliary nurse midwife has to conduct a vaccination camp in a village. She received 2 open vials, one of which is a pentavalent vaccine and the other is an MR vaccine. What can she do regarding the utilization of these vials?",
      "choices": [
        {
          "id": 1,
          "text": "Use MR vaccine and discard pentavalent vaccine"
        },
        {
          "id": 2,
          "text": "Use pentavalent vaccine and discard MR vaccine"
        },
        {
          "id": 3,
          "text": "Use both"
        },
        {
          "id": 4,
          "text": "Discard both"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>She can <strong>use </strong>the <strong>pentavalent vaccine </strong>and<strong> discard </strong>the <strong>MR vaccine.&nbsp;&nbsp;</strong>According to the <strong>open vial policy</strong>, the<strong>&nbsp;</strong>pentavalent vaccine can be reused, whereas MR can not be reused.&nbsp;</p>\n<p>Open vial policy was implemented to allow the reuse of partially used <strong>multidose vials</strong> under the Universal Immunization Program (UIP) for up to <strong>28 days&nbsp;</strong>if certain conditions are met. This was implemented to <strong>reduce vaccine wastage</strong>.</p>\n<p>It&nbsp;applies only to DPT, TT, hepatitis B, oral polio vaccine (OPV),<strong> liquid pentavalent</strong>, PCV, injectable IPV, inactivated Japanese encephalitis (JE) vaccine, and rotavirus vaccine. It does not apply to <strong>Measles/MR </strong>and<strong> </strong>BCG vaccines.</p>\n<p>Note:&nbsp;<strong>Open vial policy</strong>&nbsp;does not apply to rotavirus vaccine with VVM on cap, it applies&nbsp;<strong>only</strong>&nbsp;to&nbsp;<strong>new</strong>&nbsp;rotavirus vaccine with&nbsp;<strong>VVM on label.</strong></p><hr><h3>Related Pearl: Open Vial Policy</h3><p>Open vial policy allows for reuse of partially used <strong>multidose vials</strong> of applicable vaccines under the Universal Immunization Programme in subsequent sessions up to&nbsp;<strong>4&nbsp;weeks</strong> subject to certain conditions and thereby reducing vaccine wastage.</p>\n<p>It is applicable only for <strong>DPT, TT, hepatitis B vaccine, OPV, liquid pentavalent vaccine, rotavirus vaccine(new version with the VVM on the side), and JE vaccines (inactivated). </strong>It is not applicable to <strong>BCG and measles vaccines.&nbsp;</strong></p>\n<p>Vaccine vials opened in session-site can be used in more than one session up to four weeks if <strong>expiry date has not passed, if storage and transport was appropriate, no contamination has occurred in vial septum, asepsis in withdrawing was practiced and if vaccine vial monitor has not reached discard point.</strong></p>\n<p>Open vials should <strong>not</strong> be submerged in water. All open vials should have a record of&nbsp;<strong>date and time of opening</strong>. At the end of a session, all vaccines should be returned to the cold chain point and segregated as re-usable and non-reusable. All open vials of BCG, measles must be destroyed after 48 hours or before next session, whichever is earlier.</p>\n<p>In case of any <strong>adverse events following immunization</strong>, all open vials should not be discarded until investigation is complete. All vials must be transported in zipper bags in the vaccine carrier and recorded in stock register. Ice packs used should be well sealed.</p><hr><h3>Related Pearl: Vaccine Vial Monitors</h3><ul>\n<li><strong>Vaccine vial monitors</strong> are used to monitor heat exposure of vaccines.</li>\n<li>It is a chemical indicator that records the cumulative heat exposure through a gradual change in color.</li>\n<li>If the color of the <strong>inner square</strong> is the <strong>same color or darker</strong> than the <strong>outer circle</strong>, it indicates that the vaccine has been exposed to too much heat and it must be <strong>discarded</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3914a3eb19cf43ec9273112090e7b3f6x600x1199.JPEG\" alt=\"Pearl Image\"><ul>\n<li>Currently, there are <strong>four types</strong> of VVMs (VVM2, VVM7, VVM14, and VVM30). They are chosen to match the heat sensitivity of the vaccine.</li>\n<li>The VVM can be located on the label of the vaccine or on the neck or cap of the ampule/vial.</li>\n<li>VVMs also help in <strong>reduction of vaccine wastage</strong> by indicating which batch of vaccines can be used first.</li>\n</ul><hr><h3>Related Pearl: Cold Chain Equipment</h3><p><strong>Cold chain equipment :&nbsp;</strong></p>\n<p><strong>Storage :&nbsp;</strong></p>\n<ul>\n<li>Walk in cooler (WIC)</li>\n<li>Walk in freezer (WIF)</li>\n<li>Ice lined refrigerator (ILR)</li>\n<li>Deep freezer&nbsp;</li>\n<li>Domestic refrigerator&nbsp;</li>\n</ul>\n<p>Solar :</p>\n<ul>\n<li>Solar Refrigerator Battery drive</li>\n<li>Solar Refrigerator Direct drive</li>\n</ul>\n<p>Non electrical :</p>\n<ul>\n<li>Cold box</li>\n<li>Vaccine carrier</li>\n</ul>\n<p><strong>Transportation :&nbsp;</strong></p>\n<ul>\n<li>Refrigerator vaccine van</li>\n<li>Insulated vaccine van</li>\n<li>Cold box&nbsp;</li>\n<li>Vaccine carrier</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/549c3f139636430fa5c659529a31d432x1280x1489.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Electrical Cold Chain Equipment:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Component</strong></p>\n</td>\n<td>\n<p><strong>Temperature (degree Celsius)</strong></p>\n</td>\n<td>\n<p><strong>Level</strong></p>\n</td>\n<td>\n<p><strong>Other Comments</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Walk in Freezers (WIF)</p>\n</td>\n<td>\n<p><strong>-15 to -25&nbsp; </strong></p>\n</td>\n<td>\n<p>National, State and Regional vaccine stores</p>\n</td>\n<td>\n<p>Used for bulk storage of <strong>OPV </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Walk in Coolers (WIC)</p>\n</td>\n<td>\n<p><strong>+2 to +8</strong></p>\n</td>\n<td>\n<p>Government Medical Store Depot (GMSD), State and Regional vaccines stores</p>\n</td>\n<td>\n<p>Used for bulk storage of most vaccines in UIP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Deep Freezer (DF)</p>\n</td>\n<td>\n<p><strong>-15 to -25&nbsp; </strong></p>\n</td>\n<td>\n<p>District and Sub-district vaccines stores</p>\n</td>\n<td>\n<p>Used for bulk storage of <strong>OPV</strong> and ice packs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ice Line Refrigerator (ILR)</p>\n</td>\n<td>\n<p><strong>+2 to +8</strong></p>\n</td>\n<td>\n<p>District and Sub-district vaccines stores, <strong>PHCs</strong></p>\n</td>\n<td>\n<p>Has different <strong>temperature zones </strong>for different vaccines</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Front Load Refrigerator (Domestic)</p>\n</td>\n<td>\n<p><strong>+2 to +8</strong></p>\n</td>\n<td>\n<p>Sub-district levels, hospitals. dispensaries and nursing homes</p>\n</td>\n<td>\n<p>Used for all vaccines</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5281",
      "difficulty": "easy"
    }
  ]
}